Neurimmune and TVM Capital Life Science have partnered to create and fund a single-asset biotech focused on amyotrophic lateral sclerosis.

AbbVie has struck five-year cancer research pacts with Johns Hopkins University School of Medicine and Northwestern University's Lurie Cancer Center.

AstraZeneca has penned a pact to develop bicyclic peptides with Bicycle Therapeutics.

Sanofi has assumed responsibility for Warp Drive Bio's aminoglycoside antibiotic program.

Let’s be honest, 2016 was a mess of year, and one that many of us will be happy to see the back of. It saw the loss of a series of beloved actors, actresses…

Viralytics just reported impressive data for its virus-based cancer therapy that could bring commercial partners out of the woodwork.

Bristol-Myers has teamed with Enterome to discover microbiome-derived biomarkers, drug targets and bioactive molecules relevant to its immuno-oncology team.

Roche has put together a cancer immunotherapy research network and committed up to $100 million to support collaborations between the 21 academic centers.

Partnering